Cardiol Therapeutics Inc. (CRDL)
USD 1.14
(1.79%)
USD 1.14
(1.79%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.44 CAD | 10.2% |
| 2022 | -0.49 CAD | 32.88% |
| 2021 | -0.73 CAD | -5.8% |
| 2020 | -0.69 CAD | -30.19% |
| 2019 | -0.53 CAD | 48.54% |
| 2018 | -1.03 CAD | -1309.03% |
| 2017 | -0.07 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.14 CAD | -16.67% |
| 2024 Q2 | -0.10 CAD | 31.5% |
| 2023 Q3 | -0.09 CAD | 23.33% |
| 2023 FY | - CAD | 10.2% |
| 2023 Q1 | -0.11 CAD | 8.33% |
| 2023 Q2 | -0.12 CAD | -9.09% |
| 2023 Q4 | -0.12 CAD | -30.43% |
| 2022 FY | - CAD | 32.88% |
| 2022 Q1 | -0.14 CAD | -27.27% |
| 2022 Q4 | -0.12 CAD | 7.69% |
| 2022 Q3 | -0.13 CAD | -30.0% |
| 2022 Q2 | -0.10 CAD | 28.57% |
| 2021 Q3 | -0.23 CAD | -43.75% |
| 2021 Q4 | -0.11 CAD | 52.17% |
| 2021 Q2 | -0.16 CAD | 38.46% |
| 2021 FY | - CAD | -5.8% |
| 2021 Q1 | -0.26 CAD | 10.34% |
| 2020 FY | - CAD | -30.19% |
| 2020 Q3 | -0.13 CAD | 0.0% |
| 2020 Q2 | -0.13 CAD | -18.18% |
| 2020 Q1 | -0.11 CAD | 8.33% |
| 2020 Q4 | -0.29 CAD | -123.08% |
| 2019 Q3 | -0.13 CAD | 7.14% |
| 2019 FY | - CAD | 48.54% |
| 2019 Q4 | -0.12 CAD | 7.69% |
| 2019 Q1 | -0.14 CAD | 65.0% |
| 2019 Q2 | -0.14 CAD | 0.0% |
| 2018 Q1 | -0.02 CAD | 6.18% |
| 2018 Q3 | -0.22 CAD | -267.89% |
| 2018 Q4 | -0.40 CAD | -81.82% |
| 2018 FY | - CAD | -1309.03% |
| 2018 Q2 | -0.06 CAD | -146.09% |
| 2017 Q2 | -0.03 CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | -0.03 CAD | -9.75% |
| 2017 Q3 | -0.02 CAD | 30.38% |